Gioeli Lab discovery could lead to advancement of prostate cancer treatment

December 18, 2015 by

“The researchers determined that a cellular signaling pathway that is activated in response to radiation – to halt cell division and allow repair of damage to DNA – also controls cells’ sensitivity to androgen, a male hormone that prostate cancer cells need for growth. Androgen and androgen sensitivity, in turn, can affect how susceptible prostate cancer cells (and possibly other cancer cells) are to the radiation treatment used to kill them. “- [courtesy of UVAToday: Josh Barney and Harry Moxley; – more about the Gioeli research]